Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online June 19, 2007
Diabetes 56:2356-2370, 2007
DOI: 10.2337/db06-1650
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1650v1
56/9/2356    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehses, J. A.
Right arrow Articles by Donath, M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehses, J. A.
Right arrow Articles by Donath, M. Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

Jan A. Ehses1, Aurel Perren2, Elisabeth Eppler3, Pascale Ribaux4, John A. Pospisilik5, Ranit Maor-Cahn1, Xavier Gueripel2, Helga Ellingsgaard1, Marten K.J. Schneider6, Gregoire Biollaz7, Adriano Fontana7, Manfred Reinecke3, Francoise Homo-Delarche8, and Marc Y. Donath1

1 Division of Endocrinology and Diabetes and Center for Integrated Human Physiology, University Hospital of Zürich, Zürich, Switzerland
2 Department of Pathology, University Hospital of Zürich, Zürich, Switzerland
3 Division of Neuroendocrinology, Institute of Anatomy, University of Zürich, Zürich, Switzerland
4 Department of Genetic Medicine and Development, University Medical Center, Geneva, Switzerland
5 Institute of Molecular Biotechnology, Austrian Academy of Science, Vienna, Austria
6 Laboratory for Transplantation Immunology, University Hospital of Zürich, Zürich, Switzerland
7 Division of Clinical Immunology, University Hospital of Zürich, Zürich, Switzerland
8 Unité mixte de recherches 7059, National Center for Scientific Research, Paris 7 University/D. Diderot, Paris, France

Address correspondence and reprint requests to Dr. Jan A. Ehses, Division of Endocrinology and Diabetes, University Hospital of Zürich, Rämistrasse 100, Zürich 8091, Switzerland. E-mail: jan.ehses{at}usz.ch. Or to Dr. Marc Y. Donath, Division of Endocrinology and Diabetes, University Hospital of Zürich, Rämistrasse 100, Zürich 8091, Switzerland. E-mail: marc.donath{at}usz.ch

Abbreviations: AEC, 3-amino-9-ethylcarbazole; ECM, extracellular matrix; FITC, fluorescein isothiocyanate; G-CSF, granulocyte colony-stimulating factor; IL, interleukin; IP-10, interferon-inducible protein 10; MHC, major histocompatibility complex; MIP, macrophage inflammatory protein

Activation of the innate immune system in obesity is a risk factor for the development of type 2 diabetes. The aim of the current study was to investigate the notion that increased numbers of macrophages exist in the islets of type 2 diabetes patients and that this may be explained by a dysregulation of islet-derived inflammatory factors. Increased islet-associated immune cells were observed in human type 2 diabetic patients, high-fat–fed C57BL/6J mice, the GK rat, and the db/db mouse. When cultured islets were exposed to a type 2 diabetic milieu or when islets were isolated from high-fat–fed mice, increased islet-derived inflammatory factors were produced and released, including interleukin (IL)-6, IL-8, chemokine KC, granulocyte colony-stimulating factor, and macrophage inflammatory protein 1{alpha}. The specificity of this response was investigated by direct comparison to nonislet pancreatic tissue and ß-cell lines and was not mimicked by the induction of islet cell death. Further, this inflammatory response was found to be biologically functional, as conditioned medium from human islets exposed to a type 2 diabetic milieu could induce increased migration of monocytes and neutrophils. This migration was blocked by IL-8 neutralization, and IL-8 was localized to the human pancreatic {alpha}-cell. Therefore, islet-derived inflammatory factors are regulated by a type 2 diabetic milieu and may contribute to the macrophage infiltration of pancreatic islets that we observe in type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. S. Tessem, J. N. Jensen, H. Pelli, X.-M. Dai, X.-H. Zong, E. R. Stanley, J. Jensen, and J. DeGregori
Critical Roles for Macrophages in Islet Angiogenesis and Maintenance During Pancreatic Degeneration
Diabetes, June 1, 2008; 57(6): 1605 - 1617.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Ribaux, J. A. Ehses, N. Lin-Marq, F. Carrozzino, M. Boni-Schnetzler, E. Hammar, J.-C. Irminger, M. Y. Donath, and P. A. Halban
Induction of CXCL1 by Extracellular Matrix and Autocrine Enhancement by Interleukin-1 in Rat Pancreatic {beta}-Cells
Endocrinology, November 1, 2007; 148(11): 5582 - 5590.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.